Dice Question Streamline Icon: https://streamlinehq.com

Early-Stage Biomarkers for Cervical and Endometrial Cancers Unknown

Identify precise molecular biomarkers that are present in the early stages of cervical cancer and endometrial carcinoma to enable improved early detection and prognosis.

Information Square Streamline Icon: https://streamlinehq.com

Background

Early diagnosis is crucial for improving outcomes in CC and EC, yet reliable early-stage biomarkers have not been established, limiting screening and timely intervention.

The authors frame their integrated bioinformatics analysis as an effort to discover shared genetic biomarkers and regulatory factors, addressing the gap in early-stage biomarker identification for both diseases.

References

Precise biomarkers remain unknown in the early stages of CC and EC.

— Identification of Shared Genetic Biomarkers to Discover Candidate Drugs for Cervical and Endometrial Cancer by Using the Integrated Bioinformatics Approaches (2510.22174 - Reza et al., 25 Oct 2025) in Section 1 (Introduction)